FDA Approves Unknown Drug — SANDOZ
# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for ANDA212069, expanding its generic drug portfolio and positioning the company to capture additio…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for ANDA212069, expanding its generic drug portfolio and positioning the company to capture additio…
# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for its abbreviated new drug application (ANDA 212068), expanding the company's generic portfolio a…
Zhejiang Novus announced the receipt of FDA approval for its ANDA, a strategic milestone expected to bolster the company’s commercial portfolio and drive significant revenue growth…
# FDA Approves Caplin Steriles Limited's Intravenous Calcium Gluconate Generic The FDA has approved Caplin Steriles Limited's abbreviated new drug application for intravenous calc…
# FDA Approves Generic Drug Application from Yichang Humanwell Yichang Humanwell has received FDA approval for an abbreviated new drug application (ANDA220529), positioning the Ch…
# FDA Approves Arvinas' VEPPANU (Vepdegestrant) for Oral Administration Arvinas Operations, Inc. received FDA approval for VEPPANU (vepdegestrant), an oral selective estrogen rece…
# FDA Approves New Drug Application for Apotex Apotex received FDA approval for NDA220837 on May 1, 2026, positioning the Canadian pharmaceutical manufacturer to capture additiona…
# FDA Approves Incyte's JAKAFI XR Extended-Release Formulation Incyte Corporation received FDA approval for JAKAFI XR (ruxolitinib), an extended-release oral formulation of its fl…
MICRO LABS secured FDA approval for ANDA217239, a regulatory clearance that is expected to diversify the company's product portfolio and generate incremental sales revenue as the p…
FDA has approved the generic version of the referenced drug manufactured by IPCA LABS LTD, representing a new entry in the market. The anticipated approval creates a competitive la…
# FDA Approves Generic Sitagliptin and Metformin Hydrochloride Combination Apotex Corp. received FDA approval for its generic sitagliptin and metformin hydrochloride combination t…
# FDA Approves BPI Labs' Generic Fluorescein Sodium for Intravenous Use The FDA has approved BPI Labs LLC's abbreviated new drug application for generic fluorescein sodium injecti…
UNICHEM announced FDA approval of ANDA 219593 effective April 30, 2026, a milestone expected to bolster its market presence and diversify its revenue streams within the generic pha…
LUPIN has received FDA approval for ANDA 207694, a move that is likely to strengthen the company’s competitive positioning and broaden its market share in the relevant therapeutic …
# FDA Approves Sunshine Lake Pharma Biologic Application The U.S. Food and Drug Administration has approved Biologics License Application (BLA) 761412 for Sunshine Lake Pharma Co …
# FDA Approves HUMANWELL's Generic Drug Application HUMANWELL has received FDA approval for its abbreviated new drug application (ANDA 218740), potentially expanding its portfolio…
# FDA Approves Sun Pharma Canada Generic Drug Sun Pharma Canada has received FDA approval for a generic drug application (ANDA213919), expanding the company's portfolio in the com…
Biocon Pharma’s acquisition of an FDA approval for a generic drug substance on April 28, 2026, is anticipated to expand its United States market footprint and drive future top-line…
Micro Labs is poised to capitalize on the upcoming approval, with the generic launch expected to introduce competitive pricing pressures and capture market share from established b…
# FDA Approves Generic Fingolimod; Alembic Pharmaceuticals Enters Multiple Sclerosis Market The FDA has approved Alembic Pharmaceuticals Inc.'s generic fingolimod hydrochloride or…